Projects from ICFO, IRB Barcelona and ISGlobal have been selected in the latest round of ERC Advanced Grants. Catalonia has been awarded 3.6% of these grants in the life sciences, surpassing countries like Belgium and the Netherlands.
Acceleradora en Malalties Minoritàries de Catalunya (AMMIC) is part of the RIS3CAT community coordinated by Biocat. It is led by IUCT and other members include VHIR, Esteve, Aromics, BCN Peptides, Minoryx, Aniling and Qgenomics
Publications in top journals, rounds of investment, licensing, benchmark events held in Barcelona... 2017 was a year full of good news for the BioRegion of Catalonia. Saying goodbye to the EMA and the political instability were the bittersweet counterpoint. What can we learn from these successes and failures? From research, enterprise and management, some of the main figures take stock.
Cutting-edge studies in the best international scientific publications, rounds of investment, licenses… despite saying goodbye to the EMA and the political instability of this last quarter of the year, the Catalan healthcare and life sciences sector has maintained its role as a global benchmark for this type of ecosystem.